-
Nagi Bioscience debut at BIO International
Nagi Bioscience is thrilled to announce the successful closure of its Series A funding round co-led by Swisscanto and imec.xpand.
-
Nagi Bioscience at Swiss Biotech Day 2024
Nagi takes the stage at the Swiss Biotech Day 2024 What do we have prepared for you? Explore how you can speed-up and de-risk your pipeline with Nagi’s technology Schedule a 1:1…
-
Nagi Bioscience at ForumLabo 2024
ForumLabo, here we go ! ForumLabo Lyon 2024 is around the corner and at Nagi Bioscience we are gearing up for it! What do we have prepared for you? experience the SydLab™ one…
-
Nagi Bioscience at TAGC24
Ready for TAGC24? The Allied Genetics Conference 2024 (TAGC24) is around the corner and at Nagi Bioscience we are gearing up for it! What can you expect? SydLab™ One Live Demo at…
-
Road to SLAS 2024
Nagi Bioscience sets road to SLAS 2024 to connect with researchers and professionals, explore partnerships, and establish the basis of Nagi’s expansion plan.
-
Nagi Bioscience raises 12.4MCHF Series A round
Nagi Bioscience is thrilled to announce the successful closure of its Series A funding round co-led by Swisscanto and imec.xpand.
-
Nagi Bioscience takes the stage at EUROTOX 2023
SydLab™ One visits Ljubljana for EUROTOX 2023 to unlock the potential of micro-organisms for DART studie
-
About worms, NAMs and DART studies at WC12
Some thoughts of Nagi’s CSO Laurent Mouchiroud on NAMs in DART studies. Speaker at WC12 Niagara Falls.
-
A ‘Parts List’ for cancer’s spread: Worms to fight metastasis
C. elegans and the quest against cancer metastasis.
-
Nagi presents SydLab™ one at Worm23
Nagi Bioscience showcased its new solution for C. elegans testing – SydLab™ One – at the recently concluded 24th International C. elegans Conference in Glasgow.